263 related articles for article (PubMed ID: 30063930)
1. Perspectives on progressive strategies and recent trends in the production of recombinant human factor VIII.
Mannully ST; L N R; Pulicherla KK
Int J Biol Macromol; 2018 Nov; 119():496-504. PubMed ID: 30063930
[TBL] [Abstract][Full Text] [Related]
2. Stable high-level expression of factor VIII in Chinese hamster ovary cells in improved elongation factor-1 alpha-based system.
Orlova NA; Kovnir SV; Gabibov AG; Vorobiev II
BMC Biotechnol; 2017 Mar; 17(1):33. PubMed ID: 28340620
[TBL] [Abstract][Full Text] [Related]
3. Galectin-1 and Galectin-3 Constitute Novel-Binding Partners for Factor VIII.
O'Sullivan JM; Jenkins PV; Rawley O; Gegenbauer K; Chion A; Lavin M; Byrne B; O'Kennedy R; Preston RJ; Brophy TM; O'Donnell JS
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):855-63. PubMed ID: 27013611
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of recombinant blood coagulation factor VIII (FVIII) heavy and light chains and reconstitution of active form of FVIII.
Oh SH; Lee MY; Song DW
Exp Mol Med; 1999 Jun; 31(2):95-100. PubMed ID: 10410309
[TBL] [Abstract][Full Text] [Related]
5. Expression of factor VIII in recombinant and transgenic systems.
Soukharev S; Hammond D; Ananyeva NM; Anderson JA; Hauser CA; Pipe S; Saenko EL
Blood Cells Mol Dis; 2002; 28(2):234-48. PubMed ID: 12064919
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of the post-translational modifications of a novel, human cell line-derived recombinant human factor VIII.
Kannicht C; Ramström M; Kohla G; Tiemeyer M; Casademunt E; Walter O; Sandberg H
Thromb Res; 2013 Jan; 131(1):78-88. PubMed ID: 23058466
[TBL] [Abstract][Full Text] [Related]
7. Enhanced Proteolytic Processing of Recombinant Human Coagulation Factor VIII B-Domain Variants by Recombinant Furins.
Demasi MA; de S Molina E; Bowman-Colin C; Lojudice FH; Muras A; Sogayar MC
Mol Biotechnol; 2016 Jun; 58(6):404-14. PubMed ID: 27126696
[TBL] [Abstract][Full Text] [Related]
8. Baby hamster kidney cell-derived recombinant factor VIII: a quarter century of learning and clinical experience.
Afonja O; Kozak R; Petraro P; Michaels LA; Mathew P; Lemm G; Kessler C
Expert Rev Hematol; 2016 Dec; 9(12):1151-1164. PubMed ID: 27841041
[TBL] [Abstract][Full Text] [Related]
9. Physicochemical characterisation of rVIII-SingleChain, a novel recombinant single-chain factor VIII.
Schmidbauer S; Witzel R; Robbel L; Sebastian P; Grammel N; Metzner HJ; Schulte S
Thromb Res; 2015 Aug; 136(2):388-95. PubMed ID: 26037285
[TBL] [Abstract][Full Text] [Related]
10. Biochemical characterization and immunogenicity of Neureight, a recombinant full-length factor VIII produced by fed-batch process in disposable bioreactors.
Delignat S; Peyron I; El Ghazaly M; V Kaveri S; Rohde J; Mueller F; Lacroix-Desmazes S
Cell Immunol; 2018 Sep; 331():22-29. PubMed ID: 29751951
[TBL] [Abstract][Full Text] [Related]
11. Expression and characterization of a mutant recombinant blood coagulation factor VIII (rFVIII (m)).
Oh SH; Cho SY; Jin HS; Jeong DL; Jung SG; Oh KH
Exp Mol Med; 2002 Jul; 34(3):233-8. PubMed ID: 12216115
[TBL] [Abstract][Full Text] [Related]
12. Optimisation of the Factor VIII yield in mammalian cell cultures by reducing the membrane bound fraction.
Kolind MP; Nørby PL; Berchtold MW; Johnsen LB
J Biotechnol; 2011 Feb; 151(4):357-62. PubMed ID: 21219947
[TBL] [Abstract][Full Text] [Related]
13. Innovative approach for improved rFVIII concentrate.
Morfini M
Eur J Haematol; 2014 Nov; 93(5):361-8. PubMed ID: 24766411
[TBL] [Abstract][Full Text] [Related]
14. Transgenic pigs produce functional human factor VIII in milk.
Paleyanda RK; Velander WH; Lee TK; Scandella DH; Gwazdauskas FC; Knight JW; Hoyer LW; Drohan WN; Lubon H
Nat Biotechnol; 1997 Oct; 15(10):971-5. PubMed ID: 9335047
[TBL] [Abstract][Full Text] [Related]
15. Comparative glycosylation mapping of plasma-derived and recombinant human factor VIII.
Qu J; Ma C; Xu XQ; Xiao M; Zhang J; Li D; Liu D; Konkle BA; Miao CH; Li L; Xiao W
PLoS One; 2020; 15(5):e0233576. PubMed ID: 32442215
[TBL] [Abstract][Full Text] [Related]
16. In vitro characterization of recombinant factor VIII concentrates reveals significant differences in protein content, activity and thrombin activation profile.
Pahl S; Pavlova A; Driesen J; Müller J; Pötzsch B; Oldenburg J
Haemophilia; 2013 May; 19(3):392-8. PubMed ID: 23252674
[TBL] [Abstract][Full Text] [Related]
17. Expression and characterization of a codon-optimized blood coagulation factor VIII.
Shestopal SA; Hao JJ; Karnaukhova E; Liang Y; Ovanesov MV; Lin M; Kurasawa JH; Lee TK; Mcvey JH; Sarafanov AG
J Thromb Haemost; 2017 Apr; 15(4):709-720. PubMed ID: 28109042
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity in the tyrosine sulfation of Chinese hamster ovary cell produced recombinant FVIII.
Mikkelsen J; Thomsen J; Ezban M
Biochemistry; 1991 Feb; 30(6):1533-7. PubMed ID: 1899619
[TBL] [Abstract][Full Text] [Related]
19. Elucidation of N-linked oligosaccharide structures of recombinant human factor VIII using fluorophore-assisted carbohydrate electrophoresis.
Kumar HP; Hague C; Haley T; Starr CM; Besman MJ; Lundblad RL; Baker D
Biotechnol Appl Biochem; 1996 Dec; 24(3):207-16. PubMed ID: 8969451
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of recombinant factor VIII products in patients with hemophilia A.
Musso R
Drugs Today (Barc); 2008 Oct; 44(10):735-50. PubMed ID: 19137127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
